Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership16,495 shares
Latest Disclosed Value $ 113,980
Bnp Paribas Arbitrage, Sa reports 3.80% increase in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 16,495 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $94,846 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 15,891 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 3.80% during the quarter. The current value of the position is $86,764 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Vanda Pharmaceuticals Equity 921659108 16,495 604 3.80 114 -19.29 0.0000
2026-02-10 2025-12-31 13F Vanda Pharmaceuticals Equity 921659108 15,891 -49,644 -75.75 140 -57.19 0.0001
2025-11-13 2025-09-30 13F Vanda Pharmaceuticals Equity 921659108 65,535 56,556 629.87 327 678.57 0.0002
2025-08-14 2025-06-30 13F Vanda Pharmaceuticals Equity 921659108 8,979 -23,201 -72.10 42 -71.43 0.0000
2025-05-14 2025-03-31 13F Vanda Pharmaceuticals Equity 921659108 32,180 -40,132 -55.50 148 -57.51 0.0001
2025-02-14 2024-12-31 13F Vanda Pharmaceuticals Equity 921659108 72,312 10,074 16.19 346 18.90 0.0002
2024-11-13 2024-09-30 13F Vanda Pharmaceuticals Equity 921659108 62,238 57,393 1,184.58 292 977.78 0.0002
2024-08-13 2024-06-30 13F Vanda Pharmaceuticals Equity 921659108 4,845 -96,518 -95.22 27 -93.51 0.0000
2024-05-01 2024-03-31 13F Vanda Pharmaceuticals Equity 921659108 101,363 41,767 70.08 417 65.74 0.0004
2024-02-14 2023-12-31 13F/A-2 Vanda Pharmaceuticals Equity 921659108 59,596 20,206 51.30 251 47.65 0.0003
2024-02-07 2023-12-31 13F/A-1 Vanda Pharmaceuticals Equity 921659108 59,596 20,206 251 0.0000
2024-02-07 2023-12-31 13F Vanda Pharmaceuticals Equity 921659108 59,596 251
2023-11-14 2023-09-30 13F Vanda Pharmaceuticals Equity 921659108 39,390 -38,532 -49.45 170 -66.86 0.0002
2023-08-09 2023-06-30 13F Vanda Pharmaceuticals Equity 921659108 77,922 -84,080 -51.90 514 -53.32 0.0006
2023-05-12 2023-03-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 162,002 90,573 126.80 1,100 108.54 0.0015
2023-02-14 2022-12-31 13F Vanda Pharmaceuticals Equity 921659108 71,429 -12,529 -14.92 528 -36.43 0.0008
2022-11-16 2022-09-30 13F/A-1 Vanda Pharmaceuticals Equity 921659108 83,958 63,512 310.63 830 273.42 0.0013
2022-11-15 2022-09-30 13F Vanda Pharmaceuticals Equity 921659108 83,958 63,512 830 0.0002
2022-08-12 2022-06-30 13F Vanda Pharmaceuticals Equity 921659108 20,446 -3,862 -15.89 223 -18.98 0.0003
2022-05-18 2022-03-31 13F/A-1 Vanda Pharmaceuticals Equity 921659108 24,308 -11,701 -32.49 275 -51.42 0.0004
2022-02-09 2021-12-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 36,009 -29,704 -45.20 565 -49.91 0.0008
2021-11-16 2021-09-30 13F/A-1 VANDA PHARMACEUTICALS EQUITY 921659108 65,713 36,663 126.21 1,126 80.45 0.0016
2021-11-12 2021-09-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 13,731 -15,319 133 0.0000
2021-08-10 2021-06-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 29,050 -1,057 -3.51 625 38.05 0.0008
2021-05-07 2021-03-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 30,107 886 3.03 452 18.02 0.0007
2021-02-10 2020-12-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 29,221 15,490 112.81 384 190.15 0.0007
2020-10-30 2020-09-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 13,731 -45,192 -76.70 133 -80.42 0.0002
2020-08-06 2020-06-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 58,923 28,625 94.48 674 115.34 0.0012
2020-05-13 2020-03-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 30,298 18,471 156.18 314 61.34 0.0006
2020-02-12 2019-12-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 11,827 3,635 44.37 194 79.63 0.0004
2019-11-07 2019-09-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 8,192 2,458 42.87 109 35.00 0.0002
2019-07-30 2019-06-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 5,734 -4,952 -46.34 81 -59.18 0.0002
2019-04-25 2019-03-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 10,686 10,669 62,758.82 197 44,184.23 0.0004
2019-02-12 2018-12-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 17 -1,686 -99.00 0 -100.00 0.0000
2018-11-07 2018-09-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 1,703 0 0.00 39 21.88 0.0001
2018-07-25 2018-06-30 13F VANDA PHARMACEUTICALS EQUITY 921659108 1,703 -7,639 -81.77 32 -79.62 0.0001
2018-05-11 2018-03-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 9,342 73 0.79 157 12.14 0.0003
2018-03-05 2017-12-31 13F/A-1 VANDA PHARMACEUTICALS EQUITY 921659108 9,269 4,765 105.79 141 75.00 0.0002
2018-02-01 2017-12-31 13F VANDA PHARMACEUTICALS EQUITY 921659108 9,269 4,765 141
2017-11-03 2017-09-30 13F VANDA PHARMACEUTICALS STOCK 921659108 4,504 -284 -5.93 81 2.56 0.0002
2017-08-03 2017-06-30 13F VANDA PHARMACEUTICALS STOCK 921659108 4,788 4,581 2,213.04 78 3,800.00 0.0002
2017-05-03 2017-03-31 13F VANDA PHARMACEUTICALS STOCK 921659108 207 -1,846 -89.92 3 -93.75 0.0000
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS STOCK 921659108 2,053 -483 -19.05 33 -23.81 0.0002
2016-10-05 2016-09-30 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 2,536 -40,975 -94.17 42 -91.36 0.0002
2016-07-06 2016-06-30 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 43,511 1,411 3.35 487 38.46 0.0022
2016-04-22 2016-03-31 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 42,100 -4,756 -10.15 352 -19.50 0.0015
2016-04-19 2015-12-31 13F/A-1 * VANDA PHARMACEUTICALS INC COM STOCK 921659108 46,856 37,803 417.57 436 327.45 0.0021
2016-02-10 2015-12-31 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 46,856 436
2015-11-13 2015-09-30 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 9,053 5,576 160.37 102 131.82 0.0003
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS INC COM STOCK 921659108 3,477 2,548 274.27 44 450.00 0.0001
2015-05-15 2015-03-31 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 929 929 0.00 9 0.0000
2015-02-11 2014-12-31 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 0 -2,032 -100.00 0 -100.00
2014-11-12 2014-09-30 13F * VANDA PHARMACEUTICALS INC COM STOCK 921659108 2,032 1,602 372.56 21 320.00 0.0000
2014-04-02 2013-12-31 13F/A-1 VANDA PHARMACEUTICALS STOCK 921659108 430 430 -96.44 5 -99.99 0.0000
2013-11-13 2013-09-30 13F VANDA PHARMACEUTICALS STOCK 921659108 0 -12,078 -100.00 0 -100.00
2013-08-13 2013-06-30 13F VANDA PHARMACEUTICALS STOCK 921659108 12,078 12,078 98 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.